e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Bronchoscopic treatment of COPD and asthma: where are we going?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The safety of treating the right middle lobe with bronchial thermoplasty
T. Wiese, M. Kondapaneni (Louisville, United States Of America)
Source:
Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Session:
Bronchoscopic treatment of COPD and asthma: where are we going?
Session type:
Thematic Poster Session
Number:
2299
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Wiese, M. Kondapaneni (Louisville, United States Of America). The safety of treating the right middle lobe with bronchial thermoplasty. Eur Respir J 2013; 42: Suppl. 57, 2299
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Bronchial thermoplasty in uncontrolled severe persistent asthma. Preliminary results
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Reduction of airway smooth muscle mass in airway biopsies following bronchial thermoplasty; the TASMA randomized controlled trial
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016
Audit of bronchial thermoplasty patients who did not complete their treatment session as planned
Source: International Congress 2016 – Asthma management
Year: 2016
Bronchial thermoplasty for asthma
Source: Eur Respir Mon; 2010: 48: 228–236
Year: 2010
Exaggerated airway narrowing is related to increased airway smooth muscle mass in bronchial segments from subjects with a history of asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Bronchial thermoplasty as an option for severe asthma patients - our experiences and retrospective evaluation
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014
Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations
Source: Eur Respir J 2004; 24 : 659-663
Year: 2004
Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Simulation of airway calibre and inflammation interaction by a new model of airway epithelium
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
The effect of bronchial thermoplasty on nerve C-fibers and inflammatory cells in patients with severe asthma
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Computational modeling methods for simulating obstructive human lung diseases
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
BioPhysical bronchodilator: A new class of respiratory drug
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008
More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept